Chemclin Diagnostics Co., Ltd. (SHA:688468)
China flag China · Delayed Price · Currency is CNY
6.59
-0.10 (-1.49%)
Oct 8, 2026, 2:50 PM CST

Chemclin Diagnostics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
35.1143.91127.07147.37152.63142.76
Depreciation & Amortization
53.5356.3353.749.2951.2152.98
Other Amortization
5.115.054.383.323.064.06
Loss (Gain) From Sale of Assets
-0.69-0.12-0.51-0.18-0.070.1
Asset Writedown & Restructuring Costs
2.143.024.122.832.152.32
Loss (Gain) From Sale of Investments
-7.22-10.07-11.52-14.77-19.58-12.6
Provision & Write-off of Bad Debts
-0.090.02-0.2-0.410.020.14
Other Operating Activities
10.565.667.861.221.971.22
Change in Accounts Receivable
9.719.3526.763.826.8222.39
Change in Inventory
-1.58-7.5-1.341.127.95-25.15
Change in Accounts Payable
2.72-8.24-31.44-11.5526.114.6
Change in Other Net Operating Assets
----17.45-
Operating Cash Flow
106.8593.9167.95173.05244.56188.86
Operating Cash Flow Growth
-17.93%-44.09%-2.95%-29.24%29.49%24.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-33.66-69.88-107.49-301.37-125.28-72.55
Sale of Property, Plant & Equipment
0.860.370.220.030.020.04
Investment in Securities
18-26-39-22-10-252
Other Investing Activities
5.939.3712.2115.6620.7613.97
Investing Cash Flow
-8.87-86.14-134.06-307.68-114.5-310.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--23.71196.48--
Long-Term Debt Repaid
--29.64-8.12-13.33-11.78-11.09
Lease Payments
-10.63-9.64-8.12-13.33-11.78-11.09
Net Debt Issued (Repaid)
-30.63-29.6415.59183.16-11.78-11.09
Issuance of Common Stock
--0.85--261.35
Repurchase of Common Stock
---51.09---
Common Dividends Paid
-5.02-54.79-53.28-139.15-68.17-
Other Financing Activities
--13.87----8.26
Financing Cash Flow
-35.65-98.3-87.9344.01-79.95242

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.24-0.110.070.080.4-0.1
Net Cash Flow
62.09-90.65-53.97-90.5450.51120.22

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
73.1924.0160.46-128.32119.28116.31
Free Cash Flow Growth
43.49%-60.28%--2.55%69.43%
Free Cash Flow Margin
22.69%7.22%13.86%-28.81%25.64%24.71%
Free Cash Flow Per Share
0.190.060.15-0.320.300.30
Levered Free Cash Flow
45.89-28.6310.56-169.5493.2957.47
Unlevered Free Cash Flow
49.56-24.6213.84-169.2593.6157.93
Free Cash Flow After Leases
62.5614.3752.34-141.65107.5105.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
34.9440.4969.8796.5762.962.44
Change in Working Capital
8.39-9.91-16.95-15.6253.18-2.12